Angiodynamics (ANGO) 14.42 $ANGO
AngioDynamics (ANGO) Crumbles: Stock Falls 7.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jul 25, 7:41AM CDT
AngioDynamics (ANGO) fell over 7% in the last trading session amid huge volumes, breaking its recent volatile trend as it is currently trading below the volatile price range of last one month.
AngioDynamics Q4 Earnings Beat, Revenues Up on Higher Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 2:25PM CDT
AngioDynamics Inc. (ANGO) introduced earnings and revenue guidance for the first quarter of fiscal 2015 as well as the entire fiscal year.
Nasdaq stocks posting largest percentage decreases
AP - Thu Jul 24, 12:23PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
AngioDynamics Reports 2014 Fourth Quarter and Full Year Financial Results
GlobeNewswire - Wed Jul 23, 3:01PM CDT
-- Fourth Quarter of Fiscal 2014 Net sales increased 4% to $94.1 million; Average Daily Sales grew 7%, excluding supply agreement
AngioDynamics Awarded Novation Innovative Technology Contract Covering BioFlo PICCs and BioFlo Ports
GlobeNewswire - Mon Jul 21, 5:30AM CDT
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today receipt of an Innovative Technology Contract for the Company's BioFlo PICC and BioFlo Port products from Novation, the leading health care supply chain expertise, analytics and contracting company.
AngioDynamics to Report Fiscal 2014 Fourth Quarter and Full Year Financial Results
GlobeNewswire - Tue Jul 08, 5:30AM CDT
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2014 fourth quarter and full-year ended May 31, 2014, on Wednesday, July 23, 2014, after the close of the U.S. financial markets.
AngioDynamics' Celerity System Wins FDA Nod for PICC - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 19, 4:10PM CDT
The combined offering of the Celerity tip location system and the BioFlo PICC technology is poised to strengthen AngioDynamics Inc.'s (ANGO) Vascular Access business over the long term.
Kroger and KBR are big market movers
AP - Thu Jun 19, 3:24PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market:
Upgrade Alert for Angiodynamics (ANGO)
Comtex SmarTrend(R) - Thu Jun 19, 7:02AM CDT
Angiodynamics (NASDAQ:ANGO) was upgraded from Hold to Buy at Canaccord Genuity today. The stock closed yesterday at $15.31 on volume of 147,000 shares, above average daily volume of 97,000. In the past 52 weeks, Angiodynamics share prices have been bracketed by a low of $10.53 and a high of $19.00 and closed yesterday at $15.31, 45% above that low price. The 200-day and 50-day moving averages have moved 0.36% higher and 0.5% lower over the past week, respectively.
AngioDynamics Announces FDA Clearance for Celerity Tip Location System
GlobeNewswire - Wed Jun 18, 5:29AM CDT
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Celerity tip location system.
AngioDynamics Awarded Premier Inc.'s Supplier Horizon Award
GlobeNewswire - Wed Jun 11, 7:08AM CDT
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today it is a winner of Premier Inc.'s first Supplier Horizon Award, presented at Premier's annual Breakthroughs Conference and Exhibition at the Henry B. Gonzalez Convention Center in San Antonio.
AngioDynamics to Present at Jefferies Global Healthcare Conference
GlobeNewswire - Wed May 28, 5:38AM CDT
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Mark Frost, Executive Vice President and Chief Financial Officer, is scheduled to present at the Jefferies Global Healthcare Conference on Thursday, June 5, 2014, at 1 p.m. (ET). The conference will be held at the Grand Hyatt in New York City.
Updated Research Report on AngioDynamics - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 23, 12:10PM CDT
AngioDynamics (ANGO) lowered its adjusted earnings per share guidance for fiscal 2014 to a range of 60 to 63 cents from the prior range of 63 to 67 cents
AngioDynamics to Report Fiscal 2014 Third Quarter Financial Results
GlobeNewswire - Tue Mar 25, 5:30AM CDT
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report its fiscal 2014 third quarter financial results for the period ended February 28, 2014, on Wednesday, April 9, 2014, after the close of the U.S. financial markets.
AngioDynamics Awarded $74.9 Million in Case Against biolitec AG
GlobeNewswire - Thu Mar 20, 5:30AM CDT
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced a recent court action in its legal case against biolitec AG.
FDA Expands Angiovac Clearance for AngioDynamics - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 17, 10:42AM CDT
The expanded clearance for AngioVac cannula seems reasonable given the wide acceptance of the product across the U.S.
AngioDynamics Raised to Hold - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 11:00AM CDT
A promising guidance, an innovative pipeline and management's efforts to leverage operational activities represent a potential upside for AngioDynamics going forward.
AngioDynamics (ANGO) in Focus: Stock Moves 5.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 8:18AM CDT
AngioDynamics Inc. (ANGO) was a big mover last session, as the company saw its shares rise by roughly 6% on the day.
Wednesday's Top Upgrades (and Downgrades)
Rich Smith, The Motley Fool - Motley Fool - Wed Mar 12, 11:00AM CDT
This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on. Today, our headlines feature downgrades for clothiers Urban Outfitters and American Eagle Outfitters . But...
AngioDynamics (ANGO) Crumbles: Stock Falls 7.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jul 25, 7:41AM CDT
AngioDynamics (ANGO) fell over 7% in the last trading session amid huge volumes, breaking its recent volatile trend as it is currently trading below the volatile price range of last one month.
AngioDynamics Q4 Earnings Beat, Revenues Up on Higher Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 2:25PM CDT
AngioDynamics Inc. (ANGO) introduced earnings and revenue guidance for the first quarter of fiscal 2015 as well as the entire fiscal year.
Nasdaq stocks posting largest percentage decreases
AP - Thu Jul 24, 12:23PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
AngioDynamics Reports 2014 Fourth Quarter and Full Year Financial Results
GlobeNewswire - Wed Jul 23, 3:01PM CDT
-- Fourth Quarter of Fiscal 2014 Net sales increased 4% to $94.1 million; Average Daily Sales grew 7%, excluding supply agreement
AngioDynamics Awarded Novation Innovative Technology Contract Covering BioFlo PICCs and BioFlo Ports
GlobeNewswire - Mon Jul 21, 5:30AM CDT
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today receipt of an Innovative Technology Contract for the Company's BioFlo PICC and BioFlo Port products from Novation, the leading health care supply chain expertise, analytics and contracting company.
AngioDynamics to Report Fiscal 2014 Fourth Quarter and Full Year Financial Results
GlobeNewswire - Tue Jul 08, 5:30AM CDT
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2014 fourth quarter and full-year ended May 31, 2014, on Wednesday, July 23, 2014, after the close of the U.S. financial markets.
AngioDynamics' Celerity System Wins FDA Nod for PICC - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 19, 4:10PM CDT
The combined offering of the Celerity tip location system and the BioFlo PICC technology is poised to strengthen AngioDynamics Inc.'s (ANGO) Vascular Access business over the long term.
Kroger and KBR are big market movers
AP - Thu Jun 19, 3:24PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market:
Upgrade Alert for Angiodynamics (ANGO)
Comtex SmarTrend(R) - Thu Jun 19, 7:02AM CDT
Angiodynamics (NASDAQ:ANGO) was upgraded from Hold to Buy at Canaccord Genuity today. The stock closed yesterday at $15.31 on volume of 147,000 shares, above average daily volume of 97,000. In the past 52 weeks, Angiodynamics share prices have been bracketed by a low of $10.53 and a high of $19.00 and closed yesterday at $15.31, 45% above that low price. The 200-day and 50-day moving averages have moved 0.36% higher and 0.5% lower over the past week, respectively.
AngioDynamics Announces FDA Clearance for Celerity Tip Location System
GlobeNewswire - Wed Jun 18, 5:29AM CDT
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Celerity tip location system.
AngioDynamics Awarded Premier Inc.'s Supplier Horizon Award
GlobeNewswire - Wed Jun 11, 7:08AM CDT
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today it is a winner of Premier Inc.'s first Supplier Horizon Award, presented at Premier's annual Breakthroughs Conference and Exhibition at the Henry B. Gonzalez Convention Center in San Antonio.
AngioDynamics to Present at Jefferies Global Healthcare Conference
GlobeNewswire - Wed May 28, 5:38AM CDT
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Mark Frost, Executive Vice President and Chief Financial Officer, is scheduled to present at the Jefferies Global Healthcare Conference on Thursday, June 5, 2014, at 1 p.m. (ET). The conference will be held at the Grand Hyatt in New York City.
Updated Research Report on AngioDynamics - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 23, 12:10PM CDT
AngioDynamics (ANGO) lowered its adjusted earnings per share guidance for fiscal 2014 to a range of 60 to 63 cents from the prior range of 63 to 67 cents
AngioDynamics to Report Fiscal 2014 Third Quarter Financial Results
GlobeNewswire - Tue Mar 25, 5:30AM CDT
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report its fiscal 2014 third quarter financial results for the period ended February 28, 2014, on Wednesday, April 9, 2014, after the close of the U.S. financial markets.
AngioDynamics Awarded $74.9 Million in Case Against biolitec AG
GlobeNewswire - Thu Mar 20, 5:30AM CDT
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced a recent court action in its legal case against biolitec AG.
FDA Expands Angiovac Clearance for AngioDynamics - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 17, 10:42AM CDT
The expanded clearance for AngioVac cannula seems reasonable given the wide acceptance of the product across the U.S.
AngioDynamics Raised to Hold - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 11:00AM CDT
A promising guidance, an innovative pipeline and management's efforts to leverage operational activities represent a potential upside for AngioDynamics going forward.
AngioDynamics (ANGO) in Focus: Stock Moves 5.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 8:18AM CDT
AngioDynamics Inc. (ANGO) was a big mover last session, as the company saw its shares rise by roughly 6% on the day.
Wednesday's Top Upgrades (and Downgrades)
Rich Smith, The Motley Fool - Motley Fool - Wed Mar 12, 11:00AM CDT
This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on. Today, our headlines feature downgrades for clothiers Urban Outfitters and American Eagle Outfitters . But...
